Assessment of enoxaparin thromboprophylaxis dosing and anti-factor Xa levels in low-weight patients.

被引：0
|
作者：
Yam, Lily [1 ]
Hong, Lisa [1 ]
机构：
[1] Loma Linda Univ, Sch Pharm, Loma Linda, CA 92350 USA
来源：
PHARMACOTHERAPY | 2016年 / 36卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
89
引用
收藏
页码：E108 / E109
页数：2
相关论文
共 50 条
  • [1] Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients
    Yam, Lily
    Bahjri, Khaled
    Geslani, Van
    Cotton, Adrian
    Hong, Lisa
    [J]. PHARMACOTHERAPY, 2019, 39 (07): : 749 - 755
  • [2] Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study
    Hakeam, Hakeam A.
    Al Duhailib, Zainab
    Alsemari, Muhannad
    Alwaibah, Reem M.
    Al Shannan, Madhawi F.
    Shalhoub, Munirah
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [3] The anti-factor Xa range for low molecular weight heparin thromboprophylaxis
    Wei, Matthew Y.
    Ward, Salena M.
    [J]. HEMATOLOGY REPORTS, 2015, 7 (04) : 80 - 83
  • [4] Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis
    Jonas Wagner
    Henrike Wruck
    Anne Lautenbach
    Philipp von Kroge
    Stefan Wolter
    Oliver Mann
    Jakob Izbicki
    Anna Duprée
    [J]. Obesity Surgery, 2022, 32 : 861 - 867
  • [5] Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis
    Wagner, Jonas
    Wruck, Henrike
    Lautenbach, Anne
    von Kroge, Philipp
    Wolter, Stefan
    Mann, Oliver
    Izbicki, Jakob
    Dupree, Anna
    [J]. OBESITY SURGERY, 2022, 32 (03) : 861 - 867
  • [6] Anti-factor Xa Activity of Enoxaparin for Thromboprophylaxis in Nonsurgical Patients Is Dependent on Body Mass
    Jimenez, David
    Diaz, Gema
    Iglesias, Ana
    Cesar, Jesus
    Garcia-Avello, Angel
    Marti, David
    Escobar, Carlos
    Vidal, Rafael
    Sueiro, Antonio
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2008, 44 (12): : 660 - 663
  • [7] Prophylactic Enoxaparin Dosing Using Anti-Factor Xa Levels in Hepatic Surgery Patients: A Pilot Study
    Coster, Samuel
    Shammout, Ali
    Chaney, Michael
    Folkert, Kyra
    Grosh, Kent
    Shebrain, Saad
    Munene, Gitonga
    [J]. AMERICAN SURGEON, 2024, 90 (06) : 1760 - 1762
  • [8] ANTI-FACTOR XA LEVELS IN PICU PATIENTS ON ENOXAPARIN FOR VENOTHROMBOEMBOLISM PROPHYLAXIS
    Marshall, Amanda
    Malone, Matthew
    Yee, Addison
    [J]. CRITICAL CARE MEDICINE, 2019, 47
  • [9] Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis
    Fox, Nathan S.
    Laughon, S. Katherine
    Bender, Samuel D.
    Saltzman, Daniel H.
    Rebarber, Andrei
    [J]. OBSTETRICS AND GYNECOLOGY, 2008, 112 (04): : 884 - 889
  • [10] Anti-Factor Xa Plasma Levels in Pregnant Women Receiving Low Molecular Weight Heparin Thromboprophylaxis
    Pabinger, Ingrid
    Greinacher, Andreas
    [J]. OBSTETRICS AND GYNECOLOGY, 2009, 113 (03): : 740 - 740
12345